These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 24981842)

  • 1. Multiplexed high content screening assays create a systems cell biology approach to drug discovery.
    Taylor DL; Giuliano KA
    Drug Discov Today Technol; 2005; 2(2):149-54. PubMed ID: 24981842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiplexed high content screening assays create a systems cell biology approach to drug discovery.
    Taylor DL; Giuliano KA
    Drug Discov Today; 2005; Suppl():13-8. PubMed ID: 23570162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concise review: a high-content screening approach to stem cell research and drug discovery.
    Xia X; Wong ST
    Stem Cells; 2012 Sep; 30(9):1800-7. PubMed ID: 22821636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High content screening: seeing is believing.
    Zanella F; Lorens JB; Link W
    Trends Biotechnol; 2010 May; 28(5):237-45. PubMed ID: 20346526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The development of high-content screening (HCS) technology and its importance to drug discovery.
    Fraietta I; Gasparri F
    Expert Opin Drug Discov; 2016; 11(5):501-14. PubMed ID: 26971542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticancer drug development incorporating high-content screening and RNAi: synergistic approaches to improve target identification and validation.
    Haney SA
    Expert Opin Drug Discov; 2006 Jun; 1(1):19-29. PubMed ID: 23506030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HCS road: an enterprise system for integrated HCS data management and analysis.
    Jackson D; Lenard M; Zelensky A; Shaikh M; Scharpf JV; Shaginaw R; Nawade M; Agler M; Cloutier NJ; Fennell M; Guo Q; Wardwell-Swanson J; Zhao D; Zhu Y; Miller C; Gill J
    J Biomol Screen; 2010 Aug; 15(7):882-91. PubMed ID: 20639503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimizing the integration of immunoreagents and fluorescent probes for multiplexed high content screening assays.
    Giuliano KA
    Methods Mol Biol; 2007; 356():189-93. PubMed ID: 16988403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An overview of cell phenotypes in HCS: limitations and advantages.
    Gasparri F
    Expert Opin Drug Discov; 2009 Jun; 4(6):643-57. PubMed ID: 23489157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A high-speed liquid chromatography/tandem mass spectrometry platform using multiplexed multiple-injection chromatography controlled by single software and its application in discovery ADME screening.
    Zhang J; Vath M; Ferraro C; Li Y; Murphy K; Zvyaga T; Weller H; Shou W
    Rapid Commun Mass Spectrom; 2013 Apr; 27(7):731-7. PubMed ID: 23495019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systems cell biology based on high-content screening.
    Giuliano KA; Johnston PA; Gough A; Taylor DL
    Methods Enzymol; 2006; 414():601-19. PubMed ID: 17110213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systems cell biology knowledge created from high content screening.
    Giuliano KA; Cheung WS; Curran DP; Day BW; Kassick AJ; Lazo JS; Nelson SG; Shin Y; Taylor DL
    Assay Drug Dev Technol; 2005 Oct; 3(5):501-14. PubMed ID: 16305307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overview of informatics for high content screening.
    Dunlay RT; Czekalski WJ; Collins MA
    Methods Mol Biol; 2007; 356():269-80. PubMed ID: 16988410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential of label-free detection in high-content-screening applications.
    Proll G; Steinle L; Pröll F; Kumpf M; Moehrle B; Mehlmann M; Gauglitz G
    J Chromatogr A; 2007 Aug; 1161(1-2):2-8. PubMed ID: 17612548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benchmarking of multivariate similarity measures for high-content screening fingerprints in phenotypic drug discovery.
    Reisen F; Zhang X; Gabriel D; Selzer P
    J Biomol Screen; 2013 Dec; 18(10):1284-97. PubMed ID: 24045583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Developing a novel fiber optic fluorescence device for multiplexed high-throughput cytotoxic screening.
    Lee D; Barnes S
    J Exp Ther Oncol; 2010; 8(3):235-45. PubMed ID: 20734922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of cellular events using CellCard System in cell-based high-content multiplexed assays.
    Chen T; Hansen G; Beske O; Yates K; Zhu Y; Anthony M; Agler M; Banks M
    Expert Rev Mol Diagn; 2005 Sep; 5(5):817-29. PubMed ID: 16149883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-content screening for the discovery of pharmacological compounds: advantages, challenges and potential benefits of recent technological developments.
    Soleilhac E; Nadon R; Lafanechere L
    Expert Opin Drug Discov; 2010 Feb; 5(2):135-44. PubMed ID: 22822913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Workflow-based software environment for large-scale biological experiments.
    Kozak K; Bakos G; Hoff A; Bennett E; Dunican D; Davies A; Kelleher D; Long A; Csucs G
    J Biomol Screen; 2010 Aug; 15(7):892-9. PubMed ID: 20625182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving drug discovery with contextual assays and cellular systems analysis.
    Westwick JK; Lamerdin JE
    Methods Mol Biol; 2011; 756():61-73. PubMed ID: 21870220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.